| Jennifer Laray Scalia, | |
|
4450 Buffalo Gap Rd, Abilene, TX 79606-2703 | |
| (325) 695-4690 | |
| Not Available |
| Full Name | Jennifer Laray Scalia |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 4450 Buffalo Gap Rd, Abilene, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578178299 | NPI | - | NPPES |
| 36767 | Other | TX | TEXAS PHARMACY LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 36767 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Laray Scalia, Po Box 836, Buffalo Gap, TX 79508-0836 Ph: (325) 280-6812 | Jennifer Laray Scalia, 4450 Buffalo Gap Rd, Abilene, TX 79606-2703 Ph: (325) 695-4690 |
News Archive
"You are what you eat," the saying goes, but is what you eat playing a role in how much you sleep? Sleep, like nutrition and physical activity, is a critical determinant of health and well-being. With the increasing prevalence of obesity and its consequences, sleep researchers have begun to explore the factors that predispose individuals to weight gain and ultimately obesity.
Repligen Corporation announced today that the Office of Orphan Products Development of the Food and Drug Administration has granted orphan drug designation to RG2833, a selective histone deacetylase 3 inhibitor for the treatment of Friedreich's ataxia. Orphan drug designation qualifies Repligen to receive seven years of marketing exclusivity in the United States if the company is the first to obtain marketing approval for RG2833 for the treatment of Friedreich's ataxia.
Modern three-dimensional radiation therapy has been proven to be more successful at curing lung cancer than older two-dimensional radiation therapy for some patients with early stage lung cancer, according to a new study.
A new angiographic analysis of the CHAMPION PHOENIX trial examined the incidence and impact of stent thrombosis (ST) in patients undergoing percutaneous coronary intervention (PCI). Results of the study were released today and will be presented March 30 at the American College of Cardiology 63rd Annual Scientific Session.
› Verified 8 days ago
Dr. Molly Graham Minze, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1718 Pine St, Abilene, TX 79601 Phone: 325-676-7948 | |
Victoria Nguyen, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1005 N Judge Ely Blvd, Abilene, TX 79601 Phone: 325-672-1842 | |
Dr. Troy Walters, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 991 N Willis St, Abilene, TX 79603 Phone: 325-676-2392 | |
Dr. Rachel Marie Moore, PHARMD, BCACP,BC-ADM Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5302 Buffalo Gap Rd, Abilene, TX 79606 Phone: 325-670-4545 | |
Toni Simmons Little, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4450 Buffalo Gap Rd, Abilene, TX 79606 Phone: 325-695-4690 Fax: 325-695-5820 | |
Catherine Caroline Wright, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1900 Pine St Rm 2801, Abilene, TX 79601 Phone: 325-670-3068 | |
Mr. David Kent Johnson, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2501 Maple St, Abilene, TX 79602 Phone: 325-795-3596 Fax: 325-795-3203 |